BGLC earnings date and last-quarter result: P/E -1.04. Updated 2026-07-23.
BioNexus Gene Lab (BGLC) Research Hub
BioNexus Gene Lab (BGLC) trades on NASDAQ, MY in the Industrials (Industrial - Distribution) sector. As of 2026-10-26, shares last closed at 1.16 USD (-2.52%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.04, market cap 0.00B. This hub links to the full technical, earnings and options research available for BGLC.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Industrials (Industrial - Distribution) |
|---|---|
| Exchange | NASDAQ, MY |
| Last close | 1.16 USD (-2.52%) |
| 52-week range | 1.11 USD – 2.7 USD |
| Trend regime | Range |
| 14-day RSI | 43.5 (Bearish) |
| Trailing P/E | -1.04 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for BGLC
Covered Call on BGLC: how it works, illustrative setup around the real 1.16 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BGLC: how it works, illustrative setup around the real 1.16 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BGLC: how it works, illustrative setup around the real 1.16 USD price, max profit/loss, breakeven and when to use it. Educational.
BGLC technical analysis: range, last 1.16 USD, RSI 43.5, 52w range 1.11 USD–2.7 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BGLC in?
BioNexus Gene Lab (BGLC) is classified under Industrials (Industrial - Distribution), listed on NASDAQ, MY.
Is BGLC in an uptrend or downtrend?
As of 2026-10-26, BGLC is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BGLC's trailing P/E ratio?
BGLC's trailing P/E is -1.04, with a market cap of 0.00B. See the earnings research page for full valuation detail.